Coombes, R (2014). Cannabis regulation: high time for change?
British Medical Journal
Crippa, J, Hallak, J, Machado-de-Sousa, J, Queiroz, R, Bergamaschi, M, Chagas, M, Zuardi, A (2012). Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report. Journal of Clinical Pharmacy and Therapeutics.
Curran, VH, Brignell, C, Fletcher, S, Middleton, P, Henry, J (2002). Cognitive and subjective dose-response effects of acute oral Δ9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology
Di Forti, M, Marconi, A, Carra, E, Fraietta, S, Trotta, A, Bonomo, M, Bianconi, F, Gardner-Sood, P, O'Connor, J, Russo, M (2015). Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study. Lancet Psychiatry
Di Forti, M, Morgan, C, Dazzan, P, Pariante, C, Mondelli, V, Marques, TR, Handley, R, Luzi, S, Russo, M, Paparelli, A (2009). High-potency cannabis and the risk of psychosis. British Journal of Psychiatry
Di Forti, M, Sallis, H, Allegri, F, Trotta, A, Ferraro, L, Stilo, SA, Marconi, A, La Cascia, C, Marques, TR, Pariante, C (2013). Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophrenia Bulletin
D'Souza, DC, Perry, E, MacDougall, L, Ammerman, Y, Cooper, T, Wu, Y-T, Braley, G, Gueorguieva, R, Krystal, JH (2004). The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology
EMCDDA (2014). European Drug Report. European Monitoring Centre for Drugs and Drug Addiction.
Englund, A, Morrison, PD, Nottage, J, Hague, D, Kane, F, Bonaccorso, S, Stone, JM, Reichenberg, A, Brenneisen, R, Holt, D (2012). Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. Journal of Psychopharmacology
Field, M, Cox, WM (2008). Attentional bias in addictive behaviors: a review of its development, causes, and consequences. Drug and Alcohol Dependence
Freeman, TP, Morgan, CJ, Hindocha, C, Schafer, G, Das, RK, Curran, HV (2014). Just say ‘know’: how do cannabinoid concentrations influence users’ estimates of cannabis potency and the amount they roll in joints?
Gossop, M, Darke, S, Griffiths, P, Hando, J, Powis, B, Hall, W, Strang, J (1995). The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction
Hardwick, S, King, LA (2008). Home Office Cannabis Potency Study 2008. Home Office Scientific Development Branch: UK.
Hindocha, C, Freeman, TP, Schafer, G, Gardener, C, Das, RK, Morgan, CJ, Curran, HV (2015). Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users. European Neuropsychopharmacology
Home Office (2014). Drug Misuse: Findings from the 2013 to 2014 Crime Survey For England and Wales.
Justinova, Z, Tanda, G, Redhi, GH, Goldberg, SR (2003). Self-administration of Δ9-tetrahydrocannabinol (THC) by drug naive squirrel monkeys. Psychopharmacology
King, LA, Carpentier, C, Griffiths, P (2004). EMCDDA INSIGHTS - An Overview of Cannabis Potency in Europe. Office for Official Publications of the European Communities, Luxembourg.
Morgan, C, Gardener, C, Schafer, G, Swan, S, Demarchi, C, Freeman, T, Warrington, P, Rupasinghe, I, Ramoutar, A, Tan, N (2012). Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being. Psychological Medicine
Morgan, CJ, Schafer, G, Freeman, TP, Curran, HV (2010
a). Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study. British Journal of Psychiatry
Morgan, CJA, Curran, HV (2008). Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis. British Journal of Psychiatry
Morgan, CJA, Freeman, TP, Schafer, GL, Curran, HV (2010
b). Cannabidiol attenuates the appetitive effects of [Delta]9-Tetrahydrocannabinol in humans smoking their chosen cannabis. Neuropsychopharmacology
NDTMS (2014). Adult Drug Statistics from the National Drug Treatment Monitoring System (NDTMS). Public Health England, London.
NDTMS (2015). Young People's Statistics from the National Drug Treatment Monitoring System (NDTMS). Public Health England, London.
Pijlman, F, Rigter, S, Hoek, J, Goldschmidt, H, Niesink, R (2005). Strong increase in total delta-THC in cannabis preparations sold in Dutch coffee shops. Addiction Biology
Potter, DJ (2014). A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK. Drug Testing and Analysis
Potter, DJ, Clark, P, Brown, MB (2008). Potency of Δ9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology. Journal of Forensic Sciences
Potter, GR, Chatwin, C (2012). The problem with ‘skunk’. Drugs and Alcohol Today
Russo, EB (2011). Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology
Swift, W, Copeland, J, Hall, W (1998). Choosing a diagnostic cut-off for cannabis dependence. Addiction
Tanda, G, Munzar, P, Goldberg, SR (2000). Self-administration behavior is maintained by the psychoactive ingredient of marijuana in squirrel monkeys. Nature neuroscience
UNODC (2014). World Drug Report. United Nations Office on Drugs and Crime.
van der Pol, P, Liebregts, N, Brunt, T, Amsterdam, J, Graaf, R, Korf, DJ, Brink, W, Laar, M (2014). Cross-sectional and prospective relation of cannabis potency, dosing and smoking behaviour with cannabis dependence: an ecological study. Addiction
van der Pol, P, Liebregts, N, de Graaf, R, Korf, DJ, van den Brink, W & van Laar, M (2013). Predicting the transition from frequent cannabis use to cannabis dependence: a three-year prospective study. Drug and Alcohol Dependence
Winstock, AR, Mitcheson, LR, Deluca, P, Davey, Z, Corazza, O, Schifano, F (2011). Mephedrone, new kid for the chop?
Zuardi, A, Shirakawa, I, Finkelfarb, E, Karniol, I (1982). Action of cannabidiol on the anxiety and other effects produced by Δ9-THC in normal subjects. Psychopharmacology